Noncanonical CDK4 Signaling Rescues Diabetes in a Mouse Model by Promoting β Cell Differentiation

The authors tested whether replacement of endogenous CDK4 with the inhibitor-resistant mutant CDK4-R24C rescued the loss of β cell mass in IRS2-deficient mice.